Glucagon-Like Peptide-1 Receptor Agonists: What’s the Optimizing Policies for Obesity-Related Metabolic Diseases?

Author: Tae Sun PARK ¹
Author Information

1. Division of Endocrinology and Metabolism, Department of Internal Medicine, Jeonbuk National University Medical School, Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Korea
Publication Type:Editorial
From:Diabetes & Metabolism Journal 2025;49(2):169-171
CountryRepublic of Korea
Language:English